Nachrichten zur Johnson Service Group PLC Aktie

HURA: 2025 Financial Results

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn April 1st, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Gear Up for Johnson & Johnson (JNJ) Q1 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Streets top-and-bottom-line estimates for Johnson & Johnson (JNJ), review projections for some of its key metrics to gain…

Johnson & Johnson Aktie: Kaufchance! Beginnt jetzt die nächste Wachstumsphase?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Goldman Sachs:Goldman Sachs bestätige vor den Ergebnissen zum ersten Quartal das "buy"-Votum…

Johnson & Johnson Aktie: Höheres Kursziel trotz Branchenunsicherheit

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Citi:Die Analysten von Citi haben das Kursziel für die Aktie von Johnson…

Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know

Johnson & Johnson (JNJ) closed at $241.3 in the latest trading session, marking a +1.21% move from the prior day.…

Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030

…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Johnson & Johnson (JNJ) closed the most recent trading day at $239.93, moving +1.98% from the previous trading session.…

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) reached $238.11 at the closing of the latest trading day, reflecting a -2.09% change compared to…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

The Zacks Analyst Blog JPMorgan, Johnson & Johnson, Applied Materials and Value Line

JPMorgan, Johnson & Johnson and Applied Materials stand out in new research reports, highlighting strong business momentum despite industry and…

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Johnson & Johnson seeks EMA nod to expand Tecvayli monotherapy use in earlier-line RRMM, backed by phase III MajesTEC-9 data…

Johnson & Johnson Aktie: Medizintechnik-Sektor weiter in starker Verfassung

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Citigroup:Citi habe das Kursziel für die Aktie von Johnson & Johnson (J&J)…

Johnson Service Group PLC (JSVGF) Q4 2025 Earnings Call Prepared Remarks Transcript

…

Stockpickers: London Stock Exchange, Johnson Service Group, Greggs

Our experts discuss which companies to buy, sell or hold this week…

Scherbaums Börse: Die Stärke von Johnson & Johnson

Donald Trump zwingt Pharmakonzerne zu Preisnachlässen. Doch ausgerechnet Johnson & Johnson liefert überraschend starke Zahlen. Anleger stellen sich nun eine…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $239.63, denoting a -2.31% move from…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson has launched a website to sell some of its drugs directly to U.S. patients who either dont…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson launches website for direct-to-consumer sales…

Johnson & Johnson Aktie: BofA sieht mehr Umsatzpotenzial - Fokus auf Tecvayli und Inlexzo

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Jason Gerberry, Analyst von BofA Securities, stuft die Aktie von Johnson &…

Johnson Service Group efficiency improves margins and profit

Johnson Service Group (LON: JSG) has shown its ability to grow despite the weak consumer market hitting its core customer…

Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors

Johnson & Johnson (JNJ) closed the most recent trading day at $248.43, moving +2.04% from the previous trading session.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson wegen irreführender Werbung

Von Nicholas G. Miller DOW JONES--Die Bayer AG verklagt Johnson Johnson (JJ) und deren Sparte Janssen Biotech wegen…

Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs

JNJs diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with…

Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio

Its about striking that perfect balance between chasing growth and protecting what you already have.…

Why Is Johnson & Johnson (JNJ) Up 13% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports By Reuters

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports…

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg…

Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility

Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over…

Johnson & Johnson investing $1B to build new cell therapy facility in Montgomery County

Johnson & Johnson is investing more than $1 billion to build a new cell therapy plant in Montgomery County.…

Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory

The facility is part of the company’s plans to invest $55 billion in U.S. manufacturing, research and development and technology…

J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push

Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility…

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

• Advanced manufacturing site will utilize cutting?edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines •…

dpa-AFX ProFeed